{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Ponatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ponatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ponatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "ponatinib",
    "trial_2_text": "Ponatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Ponatinib Supplement: 60 participants will take Ponatinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ponatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ponatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.4400654137134552,
      "78": 0.3370477259159088,
      "189": 0.32336917519569397,
      "123": 0.29446351528167725,
      "188": 0.27194488048553467,
      "20": 0.23353560268878937,
      "17": 0.21267741918563843,
      "67": 0.21212360262870789,
      "228": 0.20373140275478363,
      "64": 0.2020808309316635,
      "21": 0.20016629993915558,
      "68": 0.19760486483573914,
      "173": 0.19425562024116516,
      "49": 0.18119189143180847,
      "177": 0.17945553362369537,
      "37": 0.1759098917245865,
      "46": 0.17295785248279572,
      "101": 0.16353395581245422,
      "9": 0.15173588693141937,
      "200": 0.14721542596817017,
      "350": 0.145624041557312,
      "193": 0.1430891454219818,
      "29": 0.13086514174938202,
      "191": 0.12971927225589752,
      "243": 0.12956306338310242,
      "261": 0.12381451576948166,
      "79": 0.12310946732759476,
      "2": 0.12196549028158188,
      "14": 0.12022370100021362,
      "77": 0.11948380619287491,
      "179": 0.11855354905128479,
      "239": 0.11622851341962814,
      "194": 0.11202029138803482,
      "114": 0.11059191077947617,
      "72": 0.1091659739613533,
      "104": 0.1085382029414177,
      "126": 0.10806135088205338,
      "341": 0.10106269270181656,
      "136": 0.10049718618392944,
      "5": 0.09931132942438126,
      "38": 0.09858474880456924,
      "85": 0.09293586015701294,
      "355": 0.0925433412194252,
      "27": 0.09169857949018478,
      "131": 0.09014484286308289,
      "76": 0.08496926724910736,
      "82": 0.08422796428203583,
      "234": 0.08397892862558365,
      "257": 0.08313371986150742,
      "288": 0.08298885077238083,
      "36": 0.08242163807153702,
      "186": 0.08214636147022247,
      "86": 0.08159955590963364,
      "130": 0.08149874955415726,
      "102": 0.08123598992824554,
      "28": 0.08067964017391205,
      "116": 0.0802183523774147,
      "33": 0.07873252034187317,
      "204": 0.07854072749614716,
      "122": 0.07839047908782959,
      "249": 0.07697615027427673,
      "35": 0.07604843378067017,
      "422": 0.07599984109401703,
      "18": 0.0743366926908493,
      "139": 0.07306347787380219,
      "30": 0.07244332879781723,
      "147": 0.07175111025571823,
      "396": 0.07084737718105316,
      "151": 0.07082188129425049,
      "180": 0.07029542326927185,
      "61": 0.07022546231746674,
      "212": 0.06943707168102264,
      "454": 0.06838665157556534,
      "356": 0.06766808032989502,
      "282": 0.06764719635248184,
      "124": 0.06727452576160431,
      "4": 0.06624030321836472,
      "100": 0.06313447654247284,
      "154": 0.06189533323049545,
      "269": 0.06186959147453308,
      "382": 0.06136556714773178,
      "466": 0.06118901073932648,
      "69": 0.06113686040043831,
      "211": 0.060967110097408295,
      "441": 0.0608440563082695,
      "253": 0.05961267650127411,
      "339": 0.059499602764844894,
      "144": 0.05899691954255104,
      "297": 0.0586879588663578,
      "142": 0.05840081349015236,
      "97": 0.05823836103081703,
      "276": 0.05744820460677147,
      "96": 0.05744801461696625,
      "286": 0.05660637840628624,
      "343": 0.054908592253923416,
      "213": 0.053051210939884186,
      "371": 0.051277972757816315,
      "535": 0.050678517669439316,
      "132": 0.05062482878565788,
      "342": 0.05018245428800583
    },
    "trial_2_ae": {
      "87": 0.4400654137134552,
      "78": 0.3370477259159088,
      "189": 0.32336917519569397,
      "123": 0.29446351528167725,
      "188": 0.27194488048553467,
      "20": 0.23353560268878937,
      "17": 0.21267741918563843,
      "67": 0.21212360262870789,
      "228": 0.20373140275478363,
      "64": 0.2020808309316635,
      "21": 0.20016629993915558,
      "68": 0.19760486483573914,
      "173": 0.19425562024116516,
      "49": 0.18119189143180847,
      "177": 0.17945553362369537,
      "37": 0.1759098917245865,
      "46": 0.17295785248279572,
      "101": 0.16353395581245422,
      "9": 0.15173588693141937,
      "200": 0.14721542596817017,
      "350": 0.145624041557312,
      "193": 0.1430891454219818,
      "29": 0.13086514174938202,
      "191": 0.12971927225589752,
      "243": 0.12956306338310242,
      "261": 0.12381451576948166,
      "79": 0.12310946732759476,
      "2": 0.12196549028158188,
      "14": 0.12022370100021362,
      "77": 0.11948380619287491,
      "179": 0.11855354905128479,
      "239": 0.11622851341962814,
      "194": 0.11202029138803482,
      "114": 0.11059191077947617,
      "72": 0.1091659739613533,
      "104": 0.1085382029414177,
      "126": 0.10806135088205338,
      "341": 0.10106269270181656,
      "136": 0.10049718618392944,
      "5": 0.09931132942438126,
      "38": 0.09858474880456924,
      "85": 0.09293586015701294,
      "355": 0.0925433412194252,
      "27": 0.09169857949018478,
      "131": 0.09014484286308289,
      "76": 0.08496926724910736,
      "82": 0.08422796428203583,
      "234": 0.08397892862558365,
      "257": 0.08313371986150742,
      "288": 0.08298885077238083,
      "36": 0.08242163807153702,
      "186": 0.08214636147022247,
      "86": 0.08159955590963364,
      "130": 0.08149874955415726,
      "102": 0.08123598992824554,
      "28": 0.08067964017391205,
      "116": 0.0802183523774147,
      "33": 0.07873252034187317,
      "204": 0.07854072749614716,
      "122": 0.07839047908782959,
      "249": 0.07697615027427673,
      "35": 0.07604843378067017,
      "422": 0.07599984109401703,
      "18": 0.0743366926908493,
      "139": 0.07306347787380219,
      "30": 0.07244332879781723,
      "147": 0.07175111025571823,
      "396": 0.07084737718105316,
      "151": 0.07082188129425049,
      "180": 0.07029542326927185,
      "61": 0.07022546231746674,
      "212": 0.06943707168102264,
      "454": 0.06838665157556534,
      "356": 0.06766808032989502,
      "282": 0.06764719635248184,
      "124": 0.06727452576160431,
      "4": 0.06624030321836472,
      "100": 0.06313447654247284,
      "154": 0.06189533323049545,
      "269": 0.06186959147453308,
      "382": 0.06136556714773178,
      "466": 0.06118901073932648,
      "69": 0.06113686040043831,
      "211": 0.060967110097408295,
      "441": 0.0608440563082695,
      "253": 0.05961267650127411,
      "339": 0.059499602764844894,
      "144": 0.05899691954255104,
      "297": 0.0586879588663578,
      "142": 0.05840081349015236,
      "97": 0.05823836103081703,
      "276": 0.05744820460677147,
      "96": 0.05744801461696625,
      "286": 0.05660637840628624,
      "343": 0.054908592253923416,
      "213": 0.053051210939884186,
      "371": 0.051277972757816315,
      "535": 0.050678517669439316,
      "132": 0.05062482878565788,
      "342": 0.05018245428800583
    }
  },
  "safety": {
    "trial_1_safety": 0.4092574119567871,
    "trial_2_safety": 0.4092574119567871
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4829972982406616
  }
}